Congenital Disorders of Glycosylation

November 11, 2022

The Congenital Disorders of Glycosylation session will be discussing overview of CDG and potential/existing treatments.


Commercial Supporter 

This educational activity is supported by an educational grant from Ultragenyx.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
Course opens: 
Course expires: 
Event starts: 
11/11/2022 - 12:00pm MST
Event ends: 
11/11/2022 - 1:30pm MST

Guest Faculty


Hudson Freeze, MD
Sanford Burnham Prebys Medical Discovery Institute




Hudson Freeze, MD, speaker for this session, is a consultant for GlycoMIne, BridgeBio and Avalo Therapeutics. 

Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.

All of the relevant financial relationships listed have been mitigated. 


Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Children’s Hospital Colorado designates this Other (Internet Live) activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance


Please login or register to take this course.